16 July 2019
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
12 June 2019
Exscientia has entered a multi-target partnership with China-based GT Apeiron Therapeutics.
10 June 2019
Janssen Research & Development has collaborated with software solutions provider nference to leverage artificial intelligence (AI) and data sciences for the discovery and clinical development of drugs.
4 June 2019
Eli Lilly has formed a multi-target alliance with start-up Atomwise to support preclinical drug discovery efforts.
21 May 2019
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
1 May 2019
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
30 April 2019
Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to accelerate small molecule drug discovery.
28 March 2019
Plummeting cost-to-compute is making machine learning and IoT applications more accessible than ever. Here's why that could benefit soceity's poorest.
27 March 2019
Swiss Ecole Polytechnique Fédérale de Lausanne (EPFL)’s Blue Brain Project has used a mathematical algorithm to distinguish the shape and structures of pyramidal cells.
25 March 2019
After many decades of growth, China is now the second largest global pharmaceutical market. Since the Chinese state closely controls the country’s economy, it’s unsurprising that government reforms have been...